Incannex Healthcare Limited (IXHL)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$4.09
+0.49%
Mkt Cap $48.58M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 13, 2026 | $200.00K | — | — | -$0.60 | -$0.60 | +0.00% | — | — |
| Q3 2025 Sep 29, 2025 | $200.00K | $66.62K | -66.69% | -$0.29 | -$0.39 | -34.48% | — | — |
| Q2 2025 May 15, 2025 | $312.00K | $19.38K | -93.79% | -$0.46 | -$1.01 | -120.13% | — | — |
| Q4 2024 Nov 14, 2024 | — | $108.99K | — | — | -$1.36 | — | — | — |
| Q3 2024 Sep 30, 2024 | $155.00K | $17.96K | -88.41% | -$0.76 | -$0.39 | +48.68% | — | — |
| Q2 2024 May 15, 2024 | — | — | — | — | -$1.76 | — | — | — |
| Q1 2024 Mar 1, 2024 | — | — | — | — | -$1.45 | — | — | — |
| Q4 2023 Dec 1, 2023 | — | — | — | — | $9.08 | — | — | — |
| Q3 2023 Sep 29, 2023 | — | — | — | — | -$0.21 | — | — | — |
| Q1 2023 Mar 30, 2023 | — | — | — | — | -$1.00 | — | — | — |
| Q4 2022 Dec 31, 2022 | — | — | — | — | -$0.83 | — | — | — |
| Q3 2022 Sep 30, 2022 | — | — | — | — | -$4.13 | — | — | — |
| Q3 2022 Sep 2, 2022 | — | $270.08K | — | — | -$0.32 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | $292.74K | — | — | -$0.35 | — | — | — |
| Q4 2021 Dec 31, 2021 | — | — | — | — | -$0.20 | — | — | — |
| Q3 2021 Sep 30, 2021 | — | — | — | — | -$0.20 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | $270.11K | — | — | -$0.32 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | $273.62K | — | — | -$0.33 | — | — | — |
| Q4 2020 Dec 31, 2020 | — | $453.80K | — | — | -$0.20 | — | — | — |
| Q3 2020 Sep 30, 2020 | — | $421.38K | — | — | -$0.18 | — | — | — |